or
forgot password

    • cancer clinical trials in auburn, WA

    • Study of CP-675,206 in Refractory Melanoma
    Research Site
    Auburn, Washington
    Refractory Melanoma
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Auburn Regional Medical Center
    Auburn, Washington 98002
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
    Research Site
    Auburn, Washington
    Adenocarcinoma of the Pancreas, Metastatic Pancreatic Cancer, Pancreatic Cancer
    Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
    Research Site
    Auburn, Washington
    Non-metastatic Prostate Cancer
    A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer
    Research Site
    Auburn, Washington
    Bladder Cancer, Transitional Cell Bladder Cancer, Urethra Cancer, Ureter Cancer, Renal Pelvis Cancer
    Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer
    Research Site
    Auburn, Washington
    Cancer, Carcinoma, Castrate-Resistant Prostate Cancer, Prostate Cancer, Tumors
    GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
    Research Site
    Auburn, Washington
    Adenocarcinoma of the Pancreas, Advanced Solid Tumors, Cancer, Cancer of Pancreas, Cancer of the Pancreas, Metastases, Metastatic Cancer, Metastatic Pancreatic Cancer, Pancreas Cancer, Pancreatic Cancer, Bone Metastases, Endocrine Cancer, Oncology, Oncology Patients, Solid Tumors, Advanced Malignancy
    A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
    Research Site
    Auburn, Washington
    Glioblastoma Multiforme